ETON Earnings Eton Pharmaceuticals, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–19 of 19
| Q2 2026 | 2026-06-30 | 0.41 | 2026-08-13 | 10-Q |
| Q1 2026 | 2026-03-31 | 0.05 | 2026-05-14 | 10-Q |
| Q3 2025 | 2025-09-30 | -0.23 | 2025-11-06 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.15 | 2026-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.06 | 2026-05-14 | 10-Q |
| Q3 2025 | 2024-09-30 | -0.12 | 2025-11-06 | 10-Q |
| Q2 2024 | 2024-06-30 | -0.15 | 2024-08-08 | 10-Q |
| Q1 2024 | 2024-03-31 | -0.03 | 2024-05-09 | 10-Q |
| Q3 2024 | 2023-09-30 | 0.05 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | 0.07 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.10 | 2024-05-09 | 10-Q |
| Q3 2023 | 2022-09-30 | -0.40 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.28 | 2023-08-10 | 10-Q |
| Q1 2022 | 2022-03-31 | -0.21 | 2022-05-12 | 10-Q |
| Q3 2022 | 2021-09-30 | -0.12 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | 0.12 | 2022-08-11 | 10-Q |
| Q1 2022 | 2021-03-31 | 0.19 | 2022-05-12 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.70 | 2021-08-16 | 10-Q |
| Q1 2021 | 2020-03-31 | -0.50 | 2021-05-13 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.